Astera Labs (ALAB) to Release Earnings on Tuesday

Key Points

• Astera Labs is set to release its Q2 2025 earnings on August 5th, with expectations of $0.33 earnings per share and revenue of $172.46 million.
• Recent insider trading shows significant sales, with CEO Jitendra Mohan selling 128,250 shares and CFO Michael Truett Tate selling 500,000 shares, indicating a 19.16% and 44.68% decrease in their ownership, respectively.
• Wall Street analysts have mixed ratings for Astera Labs, with target prices ranging from $75.00 to $130.00, reflecting a "Moderate Buy" consensus rating for the stock.

Astera Labs (NASDAQ:ALAB - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $172.46 million for the quarter. Astera Labs has set its Q2 2025 guidance at 0.320-0.330 EPS.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.05. Astera Labs had a net margin of 8.44% and a return on equity of 2.57%. The business had revenue of $159.44 million for the quarter, compared to analyst estimates of $151.55 million. During the same period last year, the firm earned $0.10 earnings per share. Astera Labs's revenue for the quarter was up 144.1% compared to the same quarter last year. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Stock Performance

NASDAQ:ALAB traded down $6.08 during mid-day trading on Friday, reaching $130.65. 6,037,298 shares of the company's stock were exchanged, compared to its average volume of 4,819,094. Astera Labs has a one year low of $36.22 and a one year high of $147.39. The firm has a market capitalization of $21.55 billion, a PE ratio of 595.67, a price-to-earnings-growth ratio of 6.05 and a beta of 1.18. The business's fifty day simple moving average is $98.76 and its two-hundred day simple moving average is $86.34.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 165,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 9th. The shares were sold at an average price of $98.61, for a total value of $16,270,650.00. Following the completion of the transaction, the chief operating officer directly owned 695,000 shares in the company, valued at approximately $68,533,950. This trade represents a 19.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Manuel Alba sold 13,259 shares of Astera Labs stock in a transaction that occurred on Monday, July 21st. The shares were sold at an average price of $111.00, for a total transaction of $1,471,749.00. Following the sale, the director owned 1,874,498 shares of the company's stock, valued at approximately $208,069,278. The trade was a 0.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,181,759 shares of company stock worth $200,883,431.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently bought and sold shares of the stock. Empowered Funds LLC lifted its holdings in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock worth $277,000 after acquiring an additional 4,183 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Finally, Royal Bank of Canada boosted its position in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Barclays raised their target price on shares of Astera Labs from $70.00 to $75.00 and gave the company an "overweight" rating in a report on Wednesday, May 7th. Citigroup decreased their price target on shares of Astera Labs from $120.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Stifel Nicolaus upped their price target on shares of Astera Labs from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Friday, July 18th. William Blair started coverage on shares of Astera Labs in a research note on Thursday, May 22nd. They issued an "outperform" rating on the stock. Finally, Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 22nd. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Astera Labs has an average rating of "Moderate Buy" and an average price target of $104.40.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.